Clinical Efficacy with Evolocumab among Japanese Patients in PROFICIO: A Pooled Analysis of 1,040 Patients

Key Points

• This research aims to evaluate the effectiveness of evolocumab in lowering LDL-C levels among Japanese patients.
• Pooled analysis of data from the PROFICIO program
• Involved 1,040 Japanese patients
• Focused on the impact on LDL-C levels
• Evolocumab significantly reduced LDL-C levels
• Demonstrated improvements in cardiovascular risk markers
• Highlighted its efficacy in a Japanese population